Insider Buying: ASP Isotopes Inc. (NASDAQ:ASPI) Director Buys $13,801.60 in Stock

ASP Isotopes Inc. (NASDAQ:ASPI) Director Robert John Andrew Ryan acquired 4,313 shares of ASP Isotopes stock in a transaction dated Monday, April 29th. The shares were bought at an average cost of $3.20 per share, with a total value of $13,801.60. Following the completion of the purchase, the director now owns 555,868 shares in the company, valued at $1,778,777.60. The acquisition was disclosed in a legal filing with the SEC, which is available through this link.

Robert John Andrew Ryan also recently made the following trade(s):

• On Thursday, April 25th, Robert John Andrew Ryan bought 9,500 shares of ASP Isotopes stock. The shares were bought at an average cost of $3.42 per share, with a total value of $32,490.00.

ASP Isotopes Stock Up 9.1 %

ASPI stock opened at $3.72 on Friday. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.85 and a quick ratio of 1.85. The firm has a market capitalization of $181.98 million, a P/E ratio of -7.59 and a beta of 5.15. ASP Isotopes Inc. has a 52-week low of $0.28 and a 52-week high of $4.97. The company’s 50 day simple moving average is $3.71 and its 200-day simple moving average is $2.56.

ASP Isotopes (NASDAQ:ASPI) last posted its quarterly earnings data on Wednesday, April 10th. The company reported ($0.09) earnings per share for the quarter. The business had revenue of $0.43 million for the quarter. As a group, equities research analysts anticipate that ASP Isotopes Inc. will post -0.11 EPS for the current year.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright lifted their price target on ASP Isotopes from $5.25 to $5.50 and gave the stock a “buy” rating in a research note on Wednesday, April 17th.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in ASP Isotopes stock. HTLF Bank bought a new position in ASP Isotopes Inc. (NASDAQ:ASPI) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 78,538 shares of the company’s stock, valued at approximately $141,000. HTLF Bank owned approximately 0.16% of ASP Isotopes as of its most recent SEC filing. 16.80% of the stock is currently owned by institutional investors and hedge funds.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.